tradingkey.logo

BRIEF-OliX And Lilly Enter Global Licensing Agreement For Mash And Other Cardiometabolic Indications

ReutersFeb 10, 2025 1:10 PM

- OliX Pharmaceuticals Inc 226950.KQ:

  • OLIX AND LILLY ENTER GLOBAL LICENSING AGREEMENT FOR MASH AND OTHER CARDIOMETABOLIC INDICATIONS

  • OLIX PHARMACEUTICALS INC - COLLABORATION TO DEVELOP AND COMMERCIALIZE OLX75016 FOR MASH AND CARDIOMETABOLIC INDICATIONS

  • OLIX PHARMACEUTICALS INC - TO RECEIVE INITIAL PAYMENT FROM LILLY TO COMPLETE PHASE 1 TRIAL

Source text: ID:nBwkY77Ma

Further company coverage: 226950.KQ

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI